nach oben

Current Treatment Options in Gastroenterology

Erschienen in:

20.03.2021 | Endoscopy (P Siersema, Section Editor)

Endoscopic Evaluation of Indeterminate Biliary Strictures: a Review

verfasst von: Dominic Staudenmann, MBBS (hons), FRACP, Mark Bonnichsen, MBBS (hons), FRACP, Payal Saxena, MBBS (hons) BE (hons) M Biomed E, FRACP, Arthur John Kaffes, MBBS (hons), FRACP

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Indeterminate biliary strictures present a balancing act between the potential morbidity from redundant operations and the risk of missed malignancy and disease progression. This review aims to compare and assess the efficacy of the different diagnostic techniques.

Recent findings

Until today, endoscopic retrograde cholangiopancreatography with tissue sampling was considered the standard for distinguishing benign from malignant biliary strictures. However, it is hampered by a low diagnostic yield.

Summary

Indeterminate biliary strictures remain a difficult clinical problem. Invariably, expert evaluation and review at an MDT setting should be the first step. If the diagnosis remains elusive despite the initial strategies including clinical evaluation, imaging with CT or MRI and initial sampling with either EUS or ERCP brushing, the patient should then be considered for expert IDBS evaluation. These patients should be selected for cholangioscopy with direct visualisation, direct sampling and, if available, advanced interpretive techniques such as confocal laser endomicroscopy and FISH etc. These techniques can assist in improving diagnosis and minimise delay to essential treatment and avoid unnecessary surgery. PSC remains a challenge; however, recent advances in cholangioscopy classification are proving useful in managing this cohort.

Nur mit Berechtigung zugänglich

Bowlus CL, Olson KA, Eric Gershwin M. Evaluation of indeterminate biliary strictures. Nat Rev Gastroenterol Hepatol. 2016;13:28–37.PubMedCrossRef

Tummala P, Munigala S, Eloubeidi MA, Agarwal B. Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA. J Clin Gastroenterol. 2013;47:532–7.PubMedCrossRef

Corvera CU, Blumgart LH, Darvishian F, Klimstra DS, DeMatteo R, Fong Y, et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg. 2005;201:862–9.PubMedCrossRef

Wakai T, Shirai Y, Sakata J, Maruyama T, Ohashi T, Korira PV, et al. Clinicopathological features of benign biliary strictures masquerading as biliary malignancy. Am Surg. n.d.;78(12):1388–91.

Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24:2047–60.PubMedPubMedCentralCrossRef

Saluja SS, Sharma R, Pal S, Sahni P, Chattopadhyay TK. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: A prospective study. HPB. 2007;9:373–82.PubMedCrossRef

Clayton RAE, Clarke DL, Currie EJ, Madhavan KK, Parks RW, Garden OJ. Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon. 2003;1:32–8.PubMedCrossRef

Boulay BR, Birg A. Malignant biliary obstruction: From palliation to treatment. World J Gastrointest Oncol. 2016;8:498–508.PubMedPubMedCentralCrossRef

Viesca MFY, Arvanitakis M. Early diagnosis and management of malignant distal biliary obstruction: a review on current recommendations and guidelines. Clin Exp Gastroenterol. 2019;12:415–32.CrossRef

10.

Albert JG, Filmann N, Elsner J, Moench C, Trojan J, Bojunga J, Sarrazin C, Friedrich-Rust M, Herrmann E, Bechstein WO, Zeuzem S, Hofmann WP, Long-term follow-up of endoscopic therapy in stenosis of the bilio-biliary anastomosis associated with orthotopic liver transplantation, Liver Transplant. (2013) n/a-n/a.

11.

Verdonk RC, Buis CI, Porte RJ, van der Jagt EJ, Limburg AJ, van den Berg AP, et al. Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl. 2006;12:726–35.PubMedCrossRef

12.

Krämling HJ, Hüttl TP, Heberer G. Development of gallstone surgery in Germany. Surg Endosc. 1999;13:909–13.PubMedCrossRef

13.

Sikora SS, Kumar A, Das NR, Sarkari A, Saxena R, Kapoor VK. Laparoscopic bile duct injuries: spectrum at a tertiary-care center. J Laparoendosc Adv Surg Tech - Part A. 2001;11:63–8.CrossRef

14.

Singh A, Gelrud A, Agarwal B. Biliary strictures: diagnostic considerations and approach. Gastroenterol Rep. 2015;3:22–31.CrossRef

15.

Burnett AS, Calvert TJ, Chokshi RJ. Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature. J Surg Res. 2013;184:304–11.PubMedCrossRef

16.

Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81:168–76.PubMedCrossRef

17.

Singhi D, Nikiforova M, Chennat J, Papachristou G, Khalid A, Rabinovitz M, et al. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut. 2020;69:52–61.PubMedCrossRef

18.

Athanassiadou P, Grapsa D. Value of endoscopic retrograde cholangiopancreatography-guided brushings in preoperative assessment of pancreaticobiliary strictures: what’s new? Acta Cytol. 2008;52:24–34.PubMedCrossRef

19.

• Gerges C, Beyna T, Tang RSY, Bahin F, Lau JYW, van Geenen E, et al. Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video). Gastrointest Endosc. 2020;91:1105–13 A multicenter, prospective, randomized study assessing the utility of tissue sampling during cholangioscopy compared to ERCP-brushings.PubMedCrossRef

20.

J.Y. Bang, U. Navaneethan, M. Hasan, B. Sutton, R. Hawes, S. Varadarajulu, Optimizing Outcomes of single-operator cholangioscopy-guided biopsies based on a randomized trial. Clin Gastroenterol Hepatol (2020)18:441-448.e1

21.

Baars JE, Keegan M, Bonnichsen MH, Aepli P, Theyventhiran R, Farrell E, et al. The ideal technique for processing SpyBite tissue specimens: a prospective, single-blinded, pilot-study of histology and cytology techniques. Endosc Int Open. 2019;07:E1241–7.CrossRef

22.

•• Navaneethan U, Hasan MK, Kommaraju K, Zhu X, Hebert-Magee S, Hawes RH, et al. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Gastrointest Endosc. 2016;84:649–55 A meta-analysis that shows the strength of peroral cholangioscopy and targeted biopsies in the evaluation of IDBS.PubMedCrossRef

23.

Jang S, Stevens T, Kou L, Vargo JJ, Parsi MA. Efficacy of digital single-operator cholangioscopy and factors affecting its accuracy in the evaluation of indeterminate biliary stricture. Gastrointest Endosc. 2020;91:385–393.e1.PubMedCrossRef

24.

Turowski F, Hügle U, Dormann A, Bechtler M, Jakobs R, Gottschalk U, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS^TM: results of a multicenter retrospective cohort study. Surg Endosc. 2018;32:3981–8.PubMedCrossRef

25.

• de Oliveira PVAG, de Moura DTH, Ribeiro IB, Bazarbashi AN, Franzini TAP, dos Santos MEL, et al. Efficacy of digital single-operator cholangioscopy in the visual interpretation of indeterminate biliary strictures: a systematic review and meta-analysis. Surg Endosc. 2020;34:3321–9 A meta-analysis and systemic review of the use and efficacy of visual interpretation during peroral cholangioscopy in the diagnosis of IDBS.PubMedCrossRef

26.

Nishikawa T, Tsuyuguchi T, Sakai Y, Sugiyama H, Miyazaki M, Yokosuka O. Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangioscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study. Gastrointest Endosc. 2013;77:219–26.PubMedCrossRef

27.

Xu MM, Sethi A. Diagnosing biliary malignancy, gastrointest. Endosc Clin N Am. 2015;25:677–90.

28.

Fugazza A, Sethi A, Trindade AJ, Troncone E, Devlin J, Khashab MA, et al. International multicenter comprehensive analysis of adverse events associated with lumen-apposing metal stent placement for pancreatic fluid collection drainage. Gastrointest Endosc. 2020;91:574–83.PubMedCrossRef

29.

Robles-Medranda C, Valero M, Soria-Alcivar M, Puga-Tejada M, Oleas R, Ospina-Arboleda J, et al. Reliability and accuracy of a novel classification system using peroral cholangioscopy for the diagnosis of bile duct lesions. Endoscopy. 2018;50:1059–70.PubMedCrossRef

30.

Mounzer R, Austin GL, Wani S, Brauer BC, Fukami N, Shah RJ, Per-oral video cholangiopancreatoscopy with narrow-band imaging for the evaluation of indeterminate pancreaticobiliary disease, in: Gastrointest Endosc Mosby Inc, 2017: pp. 509–517.

31.

Lee YN, Moon JH, Lee TH, Choi HJ, Itoi T, Beyna T, et al. Prospective randomized trial of a new multibending versus conventional ultra-slim endoscope for peroral cholangioscopy without device or endoscope assistance (with video). Gastrointest Endosc. 2020;91:92–101.PubMedCrossRef

32.

Korrapati P, Ciolino J, Wani S, Shah J, Watson R, Muthusamy V, et al. The efficacy of peroral cholangioscopy for difficult bile duct stones and indeterminate strictures: a systematic review and meta-analysis. Endosc Int Open. 2016;04:E263–75.CrossRef

33.

• Chiang A, Theriault M, Salim M, James P. The incremental benefit of EUS for the identification of malignancy in indeterminate extrahepatic biliary strictures: a systematic review and meta-analysis. Endosc Ultrasound. 2019;8:310 A meta-analysis highlighting the impact of EUS in IDBS.PubMedPubMedCentralCrossRef

34.

Sadeghi A, Mohamadnejad M, Islami F, Keshtkar A, Biglari M, Malekzadeh R, et al. Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointest Endosc. 2016;83:290–298.e1.PubMedCrossRef

35.

Sato N, Takano S, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, et al. Needle tract seeding recurrence of pancreatic cancer in the gastric wall with paragastric lymph node metastasis after endoscopic ultrasound-guided fine needle aspiration followed by pancreatectomy: A case report and literature review. BMC Gastroenterol. 2020;20:13.PubMedPubMedCentralCrossRef

36.

Minaga K, Takenaka M, Katanuma A, Kitano M, Yamashita Y, Kamata K, et al. Needle Tract seeding: an overlooked rare complication of endoscopic ultrasound-guided fine-needle aspiration. Oncology. 2017;93:107–12.PubMedCrossRef

37.

Meister T, Heinzow HS, Woestmeyer C, Lenz P, Menzel J, Kucharzik T, et al. Intraductal ultrasound substantiates diagnostics of bile duct strictures of uncertain etiology. World J Gastroenterol. 2013;19:874–81.PubMedPubMedCentralCrossRef

38.

Vazquez-Sequeiros E, Baron TH, Clain JE, Gostout CJ, Norton ID, Petersen BT, et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc. 2002;56:372–9.PubMedCrossRef

39.

Farrell RJ, Agarwal B, Brandwein SL, Underhill J, Chuttani R, Pleskow DK. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures. Gastrointest Endosc. 2002;56:681–7.PubMedCrossRef

40.

Tringali A, Lemmers A, Meves V, Terheggen G, Pohl J, Manfredi G, et al. Intraductal biliopancreatic imaging: European Society of Gastrointestinal Endoscopy (ESGE) technology review. Endoscopy. 2015;47:739–53.PubMedCrossRef

41.

Kim HS, Moon JH, Lee YN, Choi HJ, Lee HW, Kim HK, et al. Prospective comparison of intraductal ultrasonography-guided transpapillary biopsy and conventional biopsy on fluoroscopy in suspected malignant biliary strictures. Gut Liver. 2018;12:463–70.PubMedPubMedCentralCrossRef

42.

Fugazza A, Gaiani F, Carra MC, Brunetti F, Lévy M, Sobhani I, et al. Confocal Laser endomicroscopy in gastrointestinal and pancreatobiliary diseases: a systematic review and meta-analysis. Biomed Res Int. 2016;2016:1–31.CrossRef

43.

• Slivka A, Gan I, Jamidar P, Costamagna G, Cesaro P, Giovannini M, et al. Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: results of a prospective multicenter international study. Gastrointest Endosc. 2015;81:282–90 A prospective study evaluating the diagnostic accuracy of confocal laser endomicroscopy in IDBS.PubMedCrossRef

44.

Levy MJ, Baron TH, Clayton AC, Enders FB, Gostout CJ, Halling KC, et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol. 2008;103:1263–73.PubMedPubMedCentralCrossRef

45.

Moreno Luna LE, Kipp B, Halling KC, Sebo TJ, Kremers WK, Roberts LR, et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology. 2006;131:1064–72.PubMedPubMedCentralCrossRef

46.

Nanda A, Brown JM, Berger SH, Lewis MM, Barr Fritcher EG, Gores GJ, et al. Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Ther Adv Gastroenterol. 2015;8:56–65.CrossRef

47.

Gonda TA, Viterbo D, Gausman V, Kipp C, Sethi A, Poneros JM, et al. Mutation profile and fluorescence in situ hybridization analyses increase detection of malignancies in biliary strictures. Clin Gastroenterol Hepatol. 2017;15:913–919.e1.PubMedCrossRef

48.

• Bankov K, Döring C, Schneider M, Hartmann S, Winkelmann R, Albert JG, et al. Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma. Clin Transl Gastroenterol. 2018;9:151 A prospective study showing the diagnostic utility and potential of the next generation sequencing in biliary dysplasia and neoplasia.PubMedPubMedCentralCrossRef

49.

•• Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, et al. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut. 2020;69:52–61 A prospective study demonstrating the feasibility and potential diagnostic and therapeutic improvements with next generation sequencing and pathological evaluation in diagnosis of malignant bile duct strictures.PubMedCrossRef

50.

Chapman MH, Webster GJM, Bannoo S, Johnson GJ, Wittmann J, Pereira SP. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24:1051–8.PubMedPubMedCentralCrossRef

51.

Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies. World J Gastroenterol. 2019;25:659–71.PubMedPubMedCentralCrossRef

52.

Claessen MMH, Vleggaar FP, Tytgat KMAJ, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50:158–64.PubMedCrossRef

53.

Liu K, Wang R, Kariyawasam V, Wells M, Strasser SI, McCaughan G, et al. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver Int. 2017;37:442–8.PubMedCrossRef

54.

Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.PubMedCrossRef

55.

Lindor KD, Kowdley KV, Harrison ME. ACG clinical guideline: Primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59.PubMedCrossRef

56.

Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E, et al. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis. Hepatology. 2013;58:1084–93.PubMedCrossRef

57.

Tischendorf JJW, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol. 2007;102:107–14.PubMedCrossRef

58.

Sabino J, Vieira-Silva S, Machiels K, Joossens M, Falony G, Ballet V, et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut. 2016;65:1681–9.PubMedPubMedCentralCrossRef

59.

von Seth E, Arnelo U, Enochsson L, Bergquist A. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography. Liver Int. 2015;35:254–62.CrossRef

60.

Bangarulingam SY, Gossard AA, Petersen BT, Ott BJ, Lindor KD. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009;104:855–60.PubMedCrossRef

61.

Fung BM, Tabibian JH. Biliary endoscopy in the management of primary sclerosing cholangitis and its complications. Liver Res. 2019;3:106–17.PubMedPubMedCentralCrossRef

62.

Pohl J. Primary sclerosing cholangitis and brush cytology sampling, Video. J Encycl GI Endosc. 2013;1:528–9.

63.

Gotthardt DN, Rudolph G, Klöters-Plachky P, Kulaksiz H, Stiehl A. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc. 2010;71:527–34.PubMedCrossRef

64.

Stiehl A, Rudolph G, Klöters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol. 2002;36:151–6.PubMedCrossRef

65.

Arnelo U, Von Seth E, Bergquist A. Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis. Endoscopy. 2015;47:696–702.PubMedCrossRef

66.

Njei B, McCarty TR, Varadarajulu S, Navaneethan U. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2016;44:1139–51.PubMedCrossRef

67.

• Sandha G, D’Souza P, Halloran B, Montano-Loza AJ. A Cholangioscopy-based novel classification system for the phenotypic stratification of dominant bile duct strictures in primary sclerosing cholangitis—the edmonton classification. J Can Assoc Gastroenterol. 2018;1:174–80 A study highlighting the impact of the Edmonton Classification system on the management of IDBS and PSC.PubMedPubMedCentralCrossRef

68.

Law R, Baron TH. Endoscopic management of primary sclerosing cholangitis. Clin Liver Dis. 2014;3:79–82.CrossRef

69.

Lutz HH, Wasmuth HE, Streetz K, Tacke F, Koch A, Luedde T, et al. Endoscopic ultrasound as an early diagnostic tool for primary sclerosing cholangitis: a prospective pilot study. Endoscopy. 2012;44:934–9.PubMedCrossRef

70.

Heif M, Yen RD, Shah RJ. ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients. Dig Dis Sci. 2013;58:2068–74.PubMedCrossRef

71.

Bangarulingam SY, Bjornsson E, Enders F, Barr Fritcher EG, Gores G, Halling KC, et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology. 2010;51:174–80.PubMedCrossRef

72.

Navaneethan U, Njei B, Venkatesh PGK, Vargo JJ, Parsi MA. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79:943–950.e3.PubMedCrossRef

73.

Garrow D, Miller S, Sinha D, Conway J, Hoffman BJ, Hawes RH, et al. Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol. 2007;5:616–23.PubMedCrossRef

Titel: Endoscopic Evaluation of Indeterminate Biliary Strictures: a Review
verfasst von: Dominic Staudenmann, MBBS (hons), FRACP
Mark Bonnichsen, MBBS (hons), FRACP
Payal Saxena, MBBS (hons) BE (hons) M Biomed E, FRACP
Arthur John Kaffes, MBBS (hons), FRACP
Publikationsdatum: 20.03.2021
Verlag: Springer US
Erschienen in: Current Treatment Options in Gastroenterology / Ausgabe 2/2021
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI: https://doi.org/10.1007/s11938-021-00339-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of review

Recent findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Metabolomics in Advanced Liver Disease

Strategies to Improve Delivery of Cirrhosis Care

Management of Familial Adenomatous Polyposis

Occult Small Bowel Bleeding

Reproductive Health in IBD Patients